4Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment : a review. Otol Neurotol, 2004, 25 : 1034-1039.
5Alles MJ, der Gaag MA, Stokroos RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol, 2006, 263: 791-797.
6Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope, 1999, 109 : 1-17.
7Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol, 2001, 22: 18-23.
8Silverstein H, Thompson J, Rosenberg SI, et al. Silverstein Micro Wick. Otolaryngol Clin North Am, 2004, 37: 1019-1034.
9Hargunani CA , Kempton JB, DeGagne JM, et al. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol, 2006, 27: 564-569.
10De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endeer Rev, 2003, 24: 488-522.
8Silverstein H, Choo D, Rosengerg SI, et al. Intratympanic steroid tyertment of innerear disease and tinnitas (preliminary report ) [J]. Ear Nose Throat,1996,75 (4):468.
9McCall AA, Swan EE, Borenstein JT, et al. Drug delivery for treatment of inner ear disease : current state of knowledge [J]. Ear Hear,2010,31 (2) :156 -165.
10Wei BP, Mubiru S, O ' Leary S. Steroids for idiopathic sud- den sensorineural hearing loss [ J ]. Cochrane Database Syst Rev, 2006,25(1) :CD003998.
